Cargando…
Therapeutic anti-tumor immunity directed against neo-epitopes by intratumor delivery of mRNA encoding MLKL
In recent years, it has become increasingly clear that successful treatment of cancer is possible through the induction of anti-tumor immunity combined with killing of tumor cells. One approach to reach this is to apply cancer vaccines comprising tumor-specific antigens to elicit cellular immunity a...
Autores principales: | Van Hoecke, Lien, Saelens, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551638/ https://www.ncbi.nlm.nih.gov/pubmed/31225452 http://dx.doi.org/10.15698/cst2018.10.160 |
Ejemplares similares
-
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
por: Van Hoecke, Lien, et al.
Publicado: (2018) -
Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice
por: Van Hoecke, Lien, et al.
Publicado: (2020) -
Directing traffic: Chaperone‐mediated protein transport in malaria parasites
por: Florentin, Anat, et al.
Publicado: (2020) -
Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017) -
Red blood cell extracellular vesicles as robust carriers of RNA-based therapeutics
por: Pham, Chanh Tin, et al.
Publicado: (2018)